University Magna Graecia Of Catanzaro
University Magna Graecia Of Catanzaro is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
Inhibition of late sodium current (INa) to prevent coronary MICROvascular dysfunction in patients presenting with ST-Elevation myocardial infarction and multivessel disease: A multicenter, randomized, controlled and open label study (INaMICRON study)
Sponsor Universita' Degli Studi Di Napoli Federico II
- Start (EU)
- Latest update
- Estimated end
- Not reported
Impact of GLP1-RAs on inflammation and endothelial biomarkerS in Type 2 diABetes meLlitus patiEnts: STABLE-GLP1 trial.
Sponsor Universita' Degli Studi Di Napoli Federico II
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for University Magna Graecia Of Catanzaro?
The 2026-10-09 snapshot links University Magna Graecia Of Catanzaro to 2 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for University Magna Graecia Of Catanzaro?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to University Magna Graecia Of Catanzaro conducted?
The linked trials record locations in 1 country, including Italy. These are trial locations, not confirmed office locations or countries where University Magna Graecia Of Catanzaro delivered services.
What can this page tell me about University Magna Graecia Of Catanzaro's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under University Magna Graecia Of Catanzaro. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- University Magna Graecia Of Catanzaro